Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C29H39N3O2 |
Molecular Weight | 461.6389 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H]1NC(=O)[C@H](CC2=C(NC3=C(CC=C(C)C)C=C(CC=C(C)C)C=C23)C(C)(C)C=C)NC1=O
InChI
InChIKey=DIKMWTRJIZQJMY-CYFREDJKSA-N
InChI=1S/C29H39N3O2/c1-9-29(7,8)26-23(16-24-28(34)30-19(6)27(33)31-24)22-15-20(12-10-17(2)3)14-21(25(22)32-26)13-11-18(4)5/h9-11,14-15,19,24,32H,1,12-13,16H2,2-8H3,(H,30,34)(H,31,33)/t19-,24-/m0/s1
Molecular Formula | C29H39N3O2 |
Molecular Weight | 461.6389 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/23770564
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23770564
Echinulin is an alkaloid isolated from the fungal extract, which inhibits the protein-tyrosine phosphatase 1B (PTP1B) and can be further investigated for the treatment of diabetes.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL335 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23770564 |
29.4 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27298614
in mice: Twenty eight albino mice were fasted for 12 h prior to induction of hyperglycemia. Diabetes was induced using freshly prepared solution of alloxan monohydrate (i.p. at 120 mg/kg body weight). After the induction, the diabetic animals were randomly divided into seven groups (n = 4) and treated orally according to the following protocols:
Group B: alloxan +20 mg/kg of 1/2
Compounds echinulin (1) and arestrictin B (2), (or 1/2), two isomeric indole-containing diketopiperazine alkaloids, were obtained as a mixture (56:54). They were thus evaluated as one sample.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:43:23 GMT 2023
by
admin
on
Fri Dec 15 19:43:23 GMT 2023
|
Record UNII |
3DP19VPN8U
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m4816
Created by
admin on Fri Dec 15 19:43:23 GMT 2023 , Edited by admin on Fri Dec 15 19:43:23 GMT 2023
|
PRIMARY | Merck Index | ||
|
3DP19VPN8U
Created by
admin on Fri Dec 15 19:43:23 GMT 2023 , Edited by admin on Fri Dec 15 19:43:23 GMT 2023
|
PRIMARY | |||
|
C001132
Created by
admin on Fri Dec 15 19:43:23 GMT 2023 , Edited by admin on Fri Dec 15 19:43:23 GMT 2023
|
PRIMARY | |||
|
1859-87-6
Created by
admin on Fri Dec 15 19:43:23 GMT 2023 , Edited by admin on Fri Dec 15 19:43:23 GMT 2023
|
PRIMARY | |||
|
115252
Created by
admin on Fri Dec 15 19:43:23 GMT 2023 , Edited by admin on Fri Dec 15 19:43:23 GMT 2023
|
PRIMARY |